Eris Lifesciences gets nod to hike foreign investors’ limit to 49%

23 Aug 2017 Evaluate

Eris Lifesciences has received an approval from Reserve Bank of India (RBI) to raise foreign investors’ stake in the company to 49%. RBI notified that Foreign Institutional Investors (FIIs)/Foreign Portfolios Investors (FPIs) investment limit under Portfolio Investment Scheme (PIS) in the company has increased from 24% to 49% of its paid up capital. Also, the NRI investment limit under PIS in the company has increased from 10% to 24%.

Eris Lifesciences is engaged in manufacturing, marketing and selling of branded generics within the chronic and acute categories of the Indian Pharmaceutical Market.


Eris Lifesciences Share Price

1552.75 -5.65 (-0.36%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×